BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 19278255)

  • 1. Effect of ring size on conformation and biological activity of cyclic cationic antimicrobial peptides.
    Jelokhani-Niaraki M; Kondejewski LH; Wheaton LC; Hodges RS
    J Med Chem; 2009 Apr; 52(7):2090-7. PubMed ID: 19278255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-activity relationships of de novo designed cyclic antimicrobial peptides based on gramicidin S.
    Lee DL; Hodges RS
    Biopolymers; 2003; 71(1):28-48. PubMed ID: 12712499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of single D-amino acid substitutions on disruption of beta-sheet structure and hydrophobicity in cyclic 14-residue antimicrobial peptide analogs related to gramicidin S.
    Lee DL; Powers JP; Pflegerl K; Vasil ML; Hancock RE; Hodges RS
    J Pept Res; 2004 Feb; 63(2):69-84. PubMed ID: 15009528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformation and other biophysical properties of cyclic antimicrobial peptides in aqueous solutions.
    Jelokhani-Niaraki M; Prenner EJ; Kondejewski LH; Kay CM; McElhaney RN; Hodges RS
    J Pept Res; 2001 Oct; 58(4):293-306. PubMed ID: 11606214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel polycationic analogue of gratisin with antibiotic activity against both Gram-positive and Gram-negative bacteria.
    Tamaki M; Kokuno M; Suzuki Y; Iwama M; Shindo M; Uchida Y
    J Antibiot (Tokyo); 2008 Jan; 61(1):33-5. PubMed ID: 18305357
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conformation and interaction of the cyclic cationic antimicrobial peptides in lipid bilayers.
    Jelokhani-Niaraki M; Prenner EJ; Kay CM; McElhaney RN; Hodges RS
    J Pept Res; 2002 Jul; 60(1):23-36. PubMed ID: 12081624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation of antimicrobial and hemolytic activities in cyclic peptide diastereomers by systematic alterations in amphipathicity.
    Kondejewski LH; Jelokhani-Niaraki M; Farmer SW; Lix B; Kay CM; Sykes BD; Hancock RE; Hodges RS
    J Biol Chem; 1999 May; 274(19):13181-92. PubMed ID: 10224074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Broad-spectrum activity of membranolytic cationic macrocyclic peptides against multi-drug resistant bacteria and fungi.
    Lohan S; Konshina AG; Tiwari RK; Efremov RG; Maslennikov I; Parang K
    Eur J Pharm Sci; 2024 Jun; 197():106776. PubMed ID: 38663759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syntheses of low-hemolytic antimicrobial gratisin peptides.
    Tamaki M; Kokuno M; Sasaki I; Suzuki Y; Iwama M; Saegusa K; Kikuchi Y; Shindo M; Kimura M; Uchida Y
    Bioorg Med Chem Lett; 2009 May; 19(10):2856-9. PubMed ID: 19369073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of hydrophobicity on the antifungal activity of alpha-helical antimicrobial peptides.
    Jiang Z; Kullberg BJ; van der Lee H; Vasil AI; Hale JD; Mant CT; Hancock RE; Vasil ML; Netea MG; Hodges RS
    Chem Biol Drug Des; 2008 Dec; 72(6):483-95. PubMed ID: 19090916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of ring-size analogs of the antimicrobial peptide gramicidin S on phospholipid bilayer model membranes and on the growth of Acholeplasma laidlawii B.
    Kiricsi M; Prenner EJ; Jelokhani-Niaraki M; Lewis RN; Hodges RS; McElhaney RN
    Eur J Biochem; 2002 Dec; 269(23):5911-20. PubMed ID: 12444980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of structure and antibacterial and hemolytic activity by ring size in cyclic gramicidin S analogs.
    Kondejewski LH; Farmer SW; Wishart DS; Kay CM; Hancock RE; Hodges RS
    J Biol Chem; 1996 Oct; 271(41):25261-8. PubMed ID: 8810288
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diastereoisomeric analogues of gramicidin S: structure, biologicalactivity and interaction with lipid bilayers.
    Jelokhani-Niaraki M; Kondejewski LH; Farmer SW; Hancock RE; Kay CM; Hodges RS
    Biochem J; 2000 Aug; 349 Pt 3(Pt 3):747-55. PubMed ID: 10903135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural and biological evaluation of some loloatin C analogues.
    Tuin AW; Grotenbreg GM; Spalburg E; de Neeling AJ; Mars-Groenendijk RH; van der Marel GA; Noort D; Overkleeft HS; Overhand M
    Bioorg Med Chem; 2009 Sep; 17(17):6233-40. PubMed ID: 19679485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial peptides: synthesis and antibacterial activity of linear and cyclic drosocin and apidaecin 1b analogues.
    Gobbo M; Biondi L; Filira F; Gennaro R; Benincasa M; Scolaro B; Rocchi R
    J Med Chem; 2002 Sep; 45(20):4494-504. PubMed ID: 12238928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and membrane-disruption mechanism of charge-enriched AMPs exhibiting cell selectivity, high-salt resistance, and anti-biofilm properties.
    Han HM; Gopal R; Park Y
    Amino Acids; 2016 Feb; 48(2):505-22. PubMed ID: 26450121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Amphipathic Antimicrobial Peptide Foldamers Based on Magainin 2 Sequence.
    Goto C; Hirano M; Hayashi K; Kikuchi Y; Hara-Kudo Y; Misawa T; Demizu Y
    ChemMedChem; 2019 Nov; 14(22):1911-1916. PubMed ID: 31667994
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, Synthesis, and Evaluation of Amphiphilic Cyclic and Linear Peptides Composed of Hydrophobic and Positively-Charged Amino Acids as Antibacterial Agents.
    Riahifard N; Mozaffari S; Aldakhil T; Nunez F; Alshammari Q; Alshammari S; Yamaki J; Parang K; Tiwari RK
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30360400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in the Exploration of Therapeutic Analogues of Gramicidin S, an Old but Still Potent Antimicrobial Peptide.
    Guan Q; Huang S; Jin Y; Campagne R; Alezra V; Wan Y
    J Med Chem; 2019 Sep; 62(17):7603-7617. PubMed ID: 30938996
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bestowing antifungal and antibacterial activities by lipophilic acid conjugation to D,L-amino acid-containing antimicrobial peptides: a plausible mode of action.
    Avrahami D; Shai Y
    Biochemistry; 2003 Dec; 42(50):14946-56. PubMed ID: 14674771
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.